App-Quantinova.ai

The Effects of Chronic Stroke on Brain Function While Driving

Kristin Vesely - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

Significance of Cerebral Small Vessel Disease in Acute Intracerebral Hemorrhage: The INTERACT2 Study

Candice Delcourt - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Cerebral small vessel disease

N/A

Inflammatory Markers and Outcomes After Lacunar Stroke: the Levels of Inflammatory Markers in Treatment of Stroke Study

Leslie A. McClure - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Myocardial infarction

aspirin + clopidogrel

Location of Hemorrhage Predicts Hematoma Expansion and Poor Clinical Outcome

Andrew M Demchuk - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Intracerebral hemorrhage

N/A

Prediction of Recurrent Stroke in Lacunar Stroke Patients: Performance of the Small Vessel Disease (SVD) Score in the SPS3 Trial

Lesly Pearce - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

White matter hyperintensities

N/A

Age Related Trends in Stroke Patient Readmission

Patrice Lindsay - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Comparison of Two Methods of External Prolonged Cardiac Monitoring for the Detection of Atrial Fibrillation: Cardiophone - satellite Real Time Device vs Sorin (Automated Software) for the Peaace Study

Saad Hasan - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Arrhythmia

N/A

Prolonged Monitoring of Cardiac Rhythm With Wireless Cardiophone for Real Time Detection of Atrial Fibrillation After a Cerebral Ischemic Event (PEAACE II Study) The Edmonton Alberta Experience

Herbert Manosalva - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Arrhythmia

N/A

Mutagenesis Studies Revealed Minimal Impact of Human A120T Variant of Protease-activated Receptor 4 on Receptor function or Pharmacological Response to a Potent and Selective Antagonist

Jeffrey Colin - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Ischemic stroke

Evithrom

Cftr Deficiency Increases Systolic Blood Pressure and Exacerbates Cerebrovascular Remodeling in Angiotensin-induced Hypertension

Li-Yan Zhao - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Angiology

Cystic Fibrosis

Angiotensin II

Noninvasive Blood Flow Measures in Atherosclerosis of the Posterior Circulation: Quantitative MRA Bests TOF Signal Intensity Ratio in VERiTAS

Shyam Prabhakaran - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Coronary Artery Disease

N/A

Patient and Caregiver Physical Health During the First Year Post-stroke

Jill I Cameron - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Depression

N/A

Low Rates of Screening and Treatment for Osteoporosis Following Stroke

Jiming Fang - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Osteoporosis

N/A

Integrated Systems Enhance Equitable and High-Quality Stroke Prevention Clinic Care

Aline Bourgoin - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Quality of Ischemic Stroke-related Care in Patients With Chronic Kidney Disease (CKD) on Dialysis: Findings From Get With the Guidelines-stroke

Gregg C. Fonarow - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

End stage renal disease

N/A

Combined Coiling and Allogeneic Mesenchymal Stem/Stromal Cell Therapy Could be a More Cost-effective Alternative to Coiling Alone

Arindom Sen - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

The Association of Chronic Kidney Disease (CKD) With 30-day and 1-year Post Ischemic Stroke Mortality and Rehospitalization: Get With the Guidelines (GWTG) Stroke

Gregg C. Fonarow - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Chronic kidney disease

N/A

Incidence and Outcome of Direct Oral Anticoagulant-related Intracranial Bleeding

Michel Shamy - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Non-valvular atrial fibrillation

rivaroxaban

Neurovascular Imaging is not Always Normal in Neonatal Arterial Ischemic Stroke

Ishita Siddiq - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

Anatomical Venous Variants and Physiological Adaptive Changes in Children With Cerebral Sinovenous Thrombosis

Andrea Andrade - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Ischemic stroke

N/A

Filters

28841 Abstracts